WASHINGTON, April 13  — Blood thinners like warfarin have long been used to lower the risk of stroke in patients with atrial fibrillation, but require continuous monitoring and dietary restriction to be sure blood has not been thinned too much. Researchers at Loyola University found, however, that newer blood thinning ... Read More »

TUESDAY, April 12, 2016 — Use of the word “breakthrough” in the U.S. Food and Drug Administration’s expedited approval process could mislead doctors about the new drugs’ actual benefits, researchers warn. The U.S. Congress in 2012 gave FDA the power to designate a drug as a “breakthrough therapy” if preliminary ... Read More »